{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:01:14Z","timestamp":1781539274028,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.tube.2009.12.001","type":"journal-article","created":{"date-parts":[[2009,12,30]],"date-time":"2009-12-30T04:23:10Z","timestamp":1262146990000},"page":"39-43","source":"Crossref","is-referenced-by-count":26,"title":["GSTT1 and GSTM1 null mutations and adverse reactions induced by antituberculosis drugs in Koreans"],"prefix":"10.1016","volume":"90","author":[{"given":"Sang-Heon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Joo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Ho","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youn-Seup","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Seuk","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Koo","family":"Jee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2009.12.001_bib1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis","volume":"167","author":"Blumberg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2009.12.001_bib2","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","article-title":"Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis","volume":"167","author":"Yee","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2009.12.001_bib3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/thx.51.2.132","article-title":"Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study","volume":"51","author":"Pande","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.tube.2009.12.001_bib4","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2009.12.001_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0300-483X(00)00397-8","article-title":"Metabolic activation in drug allergies","volume":"158","author":"Park","year":"2001","journal-title":"Toxicology"},{"key":"10.1016\/j.tube.2009.12.001_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/10408440590935620","article-title":"Role of metabolism in drug-induced idiosyncratic hepatotoxicity","volume":"35","author":"Walgren","year":"2005","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.tube.2009.12.001_bib7","first-page":"994","article-title":"Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis","volume":"12","author":"Sun","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2009.12.001_bib8","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/jhep.2002.32102","article-title":"Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis","volume":"35","author":"Huang","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.tube.2009.12.001_bib9","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2217\/pgs.09.100","article-title":"Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis","volume":"10","author":"Kim","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.tube.2009.12.001_bib10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.tube.2007.05.012","article-title":"Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis","volume":"87","author":"Cho","year":"2007","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.tube.2009.12.001_bib11","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1053\/jhep.2003.50144","article-title":"Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis","volume":"37","author":"Huang","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.tube.2009.12.001_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00228-006-0111-5","article-title":"CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis","volume":"62","author":"Vuilleumier","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.tube.2009.12.001_bib13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1440-1746.2001.02585.x","article-title":"Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 \u2019null\u2019 mutation","volume":"16","author":"Roy","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.tube.2009.12.001_bib14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jhep.2007.02.009","article-title":"Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury","volume":"47","author":"Huang","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.tube.2009.12.001_bib15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1478-3231.2008.01700.x","article-title":"Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population","volume":"28","author":"Leiro","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.tube.2009.12.001_bib16","doi-asserted-by":"crossref","first-page":"E834","DOI":"10.1208\/aapsj070480","article-title":"Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin","volume":"7","author":"Roychowdhury","year":"2005","journal-title":"AAPS J"},{"key":"10.1016\/j.tube.2009.12.001_bib17","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","article-title":"Drug-related hepatotoxicity","volume":"354","author":"Navarro","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tube.2009.12.001_bib18","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3346\/jkms.2005.20.6.1089","article-title":"GSTM1, GSTT1 and GSTP1 polymorphisms in the Korean population","volume":"20","author":"Cho","year":"2005","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.tube.2009.12.001_bib19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/ACI.0b013e3282370c5f","article-title":"Human leukocyte antigens and drug hypersensitivity","volume":"7","author":"Chung","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.tube.2009.12.001_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.tpj.6500356","article-title":"A marker for Stevens\u2013Johnson syndrome: ethnicity matters","volume":"6","author":"Lonjou","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.tube.2009.12.001_bib21","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1440-1843.2006.00941.x","article-title":"Antituberculosis drugs and hepatotoxicity","volume":"11","author":"Yew","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.tube.2009.12.001_bib22","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.3748\/wjg.13.6003","article-title":"NAT2 6A, a haplotype of the N-acetyltransferase 2 gene, is an important biomarker for risk of anti-tuberculosis drug-induced hepatotoxicity in Japanese patients with tuberculosis","volume":"13","author":"Higuchi","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.tube.2009.12.001_bib23","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0140-6736(89)91909-0","article-title":"Systemic glutathione deficiency in symptom-free HIV-seropositive individuals","volume":"2","author":"Buhl","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2009.12.001_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00403-003-0446-z","article-title":"Glutathione S-transferase polymorphisms in patients with drug eruption","volume":"295","author":"Ates","year":"2004","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.tube.2009.12.001_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/tpj.2008.4","article-title":"Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions","volume":"9","author":"Nelson","year":"2009","journal-title":"Pharmacogenomics J"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979209001206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979209001206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T17:27:34Z","timestamp":1558718854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979209001206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1472979209001206"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2009.12.001","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}